Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-040324
Filing Date
2018-07-02
Accepted
2018-07-02 16:22:14
Documents
1
Period of Report
2018-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4082
  Complete submission text file 0001209191-18-040324.txt   5431
Mailing Address C/O MEDIMMUNE, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37926 | Film No.: 18932979

Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Issuer) CIK: 0001481512 (see all company filings)

EIN.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations